XJPX
3202
Market cap23mUSD
Jul 10, Last price
128.00JPY
1D
0.79%
1Q
2.40%
Jan 2017
80.28%
Name
Daitobo Co Ltd
Chart & Performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Founded in Tokyo, Japan, in 1896, Daitobo Co., Ltd. is a multifaceted enterprise with operations spanning both domestic and international markets. Its diverse business portfolio includes fashion apparel and uniforms, real estate development and management, and various healthcare-related products and services. In the realm of fashion and uniforms, Daitobo specializes in textile fabrication, offering original equipment manufacturer (OEM) services for fabrics and original design manufacturer (ODM) services for knitwear, utilizing both premium and Chinese materials. The company is also a key supplier of uniforms made from wool, cotton, and synthetic fibers, including those for government agencies. Its real estate division is actively involved in the investment and development of commercial properties, residential leasing, and the acquisition and sale of real estate assets. The healthcare segment focuses on manufacturing health-enhancing products, such as EWOOL sleeping items and other specialized goods under the Mixley Wool brand. Daitobo also engages in the wholesale and sale of futon-style home medical equipment and provides health food products like Kenyosen and SpoLife LN2. Furthermore, the company extends its manufacturing capabilities to general bedding products and offers broad OEM services, particularly from its operations in China. The company adopted its current name, Daitobo Co., Ltd., in September 2016, having previously been known as Daito Woolen Spinning & Weaving Co Ltd.
Valuation
Title JPY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026‑03 | 2025‑03 | 2024‑03 | 2023‑03 | 2022‑03 | 2021‑03 | 2020‑03 | 2019‑03 | 2018‑03 | 2017‑03 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||